Q4 2025
MEDSPT Hetzer Medical Indonesia Tbk
Laba Rugi
Neraca
Margin Profitabilitas
Return on Assets & Equity
Leverage
Income Statement Flow
Q3 2025
Loading chart...
Dupont Ratio
| Dupont Ratio | Q3 2025 | Q4 2024 | Q4 2023 | Q4 2022 | Q4 2021 | Q4 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|
| Gross Profit Margin | -6.5% | 13.3% | 55.2% | 57.0% | 0.0% | 0.0% | 0.0% |
| Operating Profit Margin | -200.0% | -135.7% | -11.5% | 12.1% | 0.0% | 0.0% | 0.0% |
| Net Profit Margin | -190.8% | -133.5% | -15.7% | 0.6% | 0.0% | 0.0% | 0.0% |
| Other Burdens | 95.4% | 98.4% | 137.2% | 5.2% | 0.0% | 0.0% | 0.0% |
| Total Asset Turnover | 0.07x | 0.10x | 0.29x | 0.47x | 0.00x | 0.00x | 0.00x |
| Equity Multiplier | 1.23x | 1.15x | 1.18x | 1.18x | 1.54x | 2.37x | 1.83x |
| Return on Asset | -14.6% | -13.3% | -3.4% | 5.6% | 0.0% | 0.0% | 0.0% |
| Return on Equity | -18.0% | -15.3% | -4.0% | 6.6% | 0.0% | 0.0% | 0.0% |
| Debt to Equity | 0.14x | 0.09x | 0.12x | 0.15x | 0.35x | 0.01x | 0.00x |
Ratio
| Ratio | Q3 2025 | Q4 2024 | Q4 2023 | Q4 2022 | Q4 2021 | Q4 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|
| Cash Ratio | 8.6% | 4.1% | 10.5% | 129.4% | 18.0% | 79.4% | 15.8% |
| Liquidity Ratio | 247.9% | 287.7% | 371.6% | 902.5% | 191.1% | 121.5% | 164.2% |
| Interest Coverage | -1633.0% | -1798.0% | -392.0% | 600.0% | 0.0% | 0.0% | 0.0% |
| Operating Cash Flow to Investing Cash Flow | 1864.0% | -617.6% | 51.8% | -73.5% | 0.0% | 0.0% | 0.0% |
| Quality of Earnings | 36.9% | -26.1% | -88.3% | -5493.7% | 0.0% | 0.0% | 0.0% |
| Cash received to Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Financial
Format: Juta (jt)
| Rupiah | Q3 2025 | Q4 2024 | Q4 2023 | Q4 2022 | Q4 2021 | Q4 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|
| Pendapatan | 4.582,04 | 6.391,01 | 22.723,32 | 37.737,43 | 0 | 0 | 0 |
| Laba Kotor | -299,62 | 850,53 | 12.540,61 | 21.502,87 | 0 | 0 | 0 |
| Laba Usaha | -9.164,38 | -8.673,57 | -2.603,04 | 4.553,3 | 0 | 0 | 0 |
| Laba Bersih | -8.741,52 | -8.533,55 | -3.570,48 | 237,06 | 0 | 0 | 0 |
| Aset | 62.633,89 | 65.306,44 | 77.125,21 | 80.927,42 | 49.980,8 | 30.885,25 | 7.743,12 |
| Ekuitas | 50.895,61 | 56.616,75 | 65.155,79 | 68.787,29 | 32.463,44 | 13.027,78 | 4.228,65 |
| Liabilitas | 11.738,28 | 8.689,7 | 11.969,42 | 12.140,13 | 17.517,37 | 17.857,47 | 3.514,46 |
| Operating Cash Flow | -3.222 | 2.230 | 3.152,15 | -13.023,42 | 0 | 0 | 0 |
| Investing Cash Flow | 172,85 | 361,09 | -6.087,84 | -17.728,06 | 0 | 0 | 0 |
| Financing Cash Flow | 3.222,95 | -3.024,57 | -1.760,56 | 34.711,8 | 0 | 0 | 0 |
Financial Growth
| Growth % | Q3 2025 | Q4 2024 | Q4 2023 | Q4 2022 | Q4 2021 | Q4 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|
| Pendapatan | -28.3% | -71.9% | -39.8% | 0 | 0 | 0 | 0 |
| Laba Kotor | -135.2% | -93.2% | -41.7% | 0 | 0 | 0 | 0 |
| Laba Usaha | 5.7% | 233.2% | -157.2% | 0 | 0 | 0 | 0 |
| Laba Bersih | 2.4% | 139.0% | -1606.1% | 0 | 0 | 0 | 0 |
| Aset | -4.1% | -15.3% | -4.7% | 61.9% | 61.8% | 298.9% | 0.0% |
| Ekuitas | -10.1% | -13.1% | -5.3% | 111.9% | 149.2% | 208.1% | 0.0% |
| Liabilitas | 35.1% | -27.4% | -1.4% | -30.7% | -1.9% | 408.1% | 0.0% |
| Operating Cash Flow | -244.5% | -29.3% | -124.2% | 0 | 0 | 0 | 0 |
| Investing Cash Flow | -52.1% | -105.9% | -65.7% | 0 | 0 | 0 | 0 |
| Financing Cash Flow | -206.6% | 71.8% | -105.1% | 0 | 0 | 0 | 0 |